| Patient no. | LFR | ||
---|---|---|---|---|
Low | High | P | ||
Age (y) | Â | Â | Â | 0.11 |
 < 60 | 88 | 45 | 43 |  |
 ≥ 60 | 101 | 64 | 37 |  |
Gender | Â | Â | Â | 0.54 |
 Male | 119 | 71 | 48 |  |
 Female | 70 | 38 | 32 |  |
Tobacco use history | Â | Â | Â | 0.20 |
 Never | 132 | 72 | 60 |  |
 Current + former | 57 | 37 | 20 |  |
Alcohol use history | Â | Â | Â | 0.13 |
 Never | 117 | 62 | 55 |  |
 Current + former | 72 | 47 | 25 |  |
Hypertension | Â | Â | Â | 0.86 |
 Without | 150 | 86 | 64 |  |
 With | 39 | 23 | 16 |  |
Type 2 diabetes | Â | Â | Â | 0.63 |
 Without | 169 | 96 | 73 |  |
 With | 20 | 13 | 7 |  |
Tumor sites | Â | Â | Â | 0.62 |
 Right | 52 | 28 | 24 |  |
 Left | 137 | 81 | 56 |  |
Histological grade | Â | Â | Â | 0.22 |
 Well + moderate | 160 | 89 | 71 |  |
 Poor | 29 | 20 | 9 |  |
Mucinous constituent | Â | Â | Â | 0.25 |
 Without | 156 | 93 | 63 |  |
 With | 33 | 16 | 17 |  |
Tumor deposits | Â | Â | Â | 0.01* |
 Without | 172 | 94 | 78 |  |
 With | 17 | 15 | 2 |  |
CEA level | Â | Â | Â | < 0.01* |
 Normal | 120 | 60 | 60 |  |
 Elevated | 69 | 49 | 20 |  |
CA19-9 level | Â | Â | Â | 0.04* |
 Normal | 160 | 87 | 73 |  |
 Elevated | 29 | 22 | 7 |  |
Combined T stages | Â | Â | Â | < 0.01* |
 T1 + T2 | 52 | 16 | 36 |  |
 T3 + T4 | 137 | 93 | 44 |  |
Combined N stages | Â | Â | Â | 0.13 |
 N0 | 115 | 61 | 54 |  |
 N1 + N2 | 74 | 48 | 26 |  |
TNM stages | Â | Â | Â | < 0.01* |
 I | 40 | 12 | 28 |  |
 II | 77 | 50 | 27 |  |
 III | 72 | 47 | 25 |  |
BMI (kg/m2) | 189 | 22.95 ± 3.62 | 23.83 ± 3.42 | 0.09 |